Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-10-008890
Filing Date
2010-02-23
Accepted
2010-02-23 17:14:30
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a10-1548_110k.htm 10-K 4803322
2 EX-21 a10-1548_1ex21.htm EX-21 5867
3 EX-23.1 a10-1548_1ex23d1.htm EX-23.1 2307
4 EX-31.1 a10-1548_1ex31d1.htm EX-31.1 11688
5 EX-31.2 a10-1548_1ex31d2.htm EX-31.2 11836
6 EX-32.1 a10-1548_1ex32d1.htm EX-32.1 5789
7 EX-32.2 a10-1548_1ex32d2.htm EX-32.2 5875
8 GRAPHIC g15481ba07i001.jpg GRAPHIC 16934
9 GRAPHIC g15481ba07i002.jpg GRAPHIC 7516
10 GRAPHIC g15481ba13i001.jpg GRAPHIC 18919
  Complete submission text file 0001104659-10-008890.txt   4908364
Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Filer) CIK: 0001405197 (see all company filings)

EIN.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34473 | Film No.: 10627346
SIC: 2834 Pharmaceutical Preparations